전남대학교 중앙도서관

Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8 + TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.

학술저널

issue: The Journal of pathology [J Pathol] 2022 Apr; Vol. 256 (4), pp. 388-401. Date of Electronic Publication: 2022 Feb 07.
Author: Heinze K; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Nazeran TM; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Lee S; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada.
Krämer P; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
Cairns ES; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.
Chiu DS; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Leung SC; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Kang EY; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada.
Meagher NS; University of New South Wales, Adult Cancer Program, Lowy Cancer Research Centre, Sydney, Australia.; University of New South Wales, School of Women's and Children's Health, Sydney, Australia.
Kennedy CJ; The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.
Boros J; The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.
Kommoss F; Medizin Campus Bodensee, Institute of Pathology, Friedrichshafen, Germany.
Vollert HW; Department of Gynecology and Obstetrics, Medizin Campus Bodensee, Friedrichshafen, Germany.
Heitz F; Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany.
du Bois A; Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany.
Harter P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany.
Grube M; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
Kraemer B; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
Staebler A; University Hospital Tübingen, Institute of Pathology and Neuropathology, Tübingen, Germany.
Kommoss FK; University Hospital Heidelberg, Institute of Pathology, Heidelberg, Germany.
Heublein S; Department of Obstetrics and Gynecology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany.
Sinn HP; University Hospital Heidelberg, Institute of Pathology, Heidelberg, Germany.
Singh N; Department of Pathology, Barts Health National Health Service Trust, London, UK.
Laslavic A; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Elishaev E; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Olawaiye A; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Moysich K; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Modugno F; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sharma R; Westmead Hospital, Tissue Pathology and Diagnostic Oncology, Sydney, Australia.; University of Sydney, Sydney, Australia.; Western Sydney University, Sydney, Australia.
Brand AH; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia.
Harnett PR; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia.
DeFazio A; The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia.; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, Australia.
Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lubinski J; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Lener M; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Tołoczko-Grabarek A; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Cybulski C; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Gronwald H; Department of Propaedeutics, Physical Diagnostics and Dental Physiotherapy, Pomeranian Medical University, Szczecin, Poland.
Gronwald J; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Coulson P; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
El-Bahrawy MA; Department of Metabolism, Digestion and Reproduction, Hammersmith Hospital, Imperial College London, London, UK.
Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
Gorringe KL; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Peter MacCallum Cancer Centre, Women's Cancer Program, Melbourne, Australia.
Campbell I; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Peter MacCallum Cancer Centre, Cancer Genetics Laboratory, Research Division, Melbourne, Australia.
Cook L; Division of Epidemiology and Biostatistics, The University of New Mexico, Albuquerque, NM, USA.
Gayther SA; Cedars-Sinai Medical Center, Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Los Angeles, CA, USA.
Carney ME; Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Shvetsov YB; University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA.
Hernandez BY; University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA.
Wilkens LR; University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA.
Goodman MT; Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, CA, USA.
Mateoiu C; Department of Obstetrics and Gynecology, Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Gothenburg, Sweden.
Linder A; Department of Obstetrics and Gynecology, Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Gothenburg, Sweden.
Sundfeldt K; Department of Obstetrics and Gynecology, Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Gothenburg, Sweden.
Kelemen LE; Hollings Cancer Center and Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Gentry-Maharaj A; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.; University College London, Department of Women's Cancer, Institute for Women's Health, London, UK.
Widschwendter M; University of Innsbruck, EUTOPS Institute, Innsbruck, Austria.
Menon U; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.
Bolton KL; Department of Hematology and Oncology, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Alsop J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Shah M; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK.
Jimenez-Linan M; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK.
Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Brenton JD; University of Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK.
Cushing-Haugen KL; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Harris HR; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Doherty JA; Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.
Gilks B; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Ghatage P; Department of Oncology, Division of Gynecologic Oncology, University of Calgary, Calgary, Canada.
Huntsman DG; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Nelson GS; Department of Oncology, Division of Gynecologic Oncology, University of Calgary, Calgary, Canada.
Tinker AV; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.; Department of Medicine, University of British Columbia, Vancouver, Canada.
Lee CH; University of Alberta, Department of Laboratory Medicine and Pathology, Edmonton, Canada.
Goode EL; Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, MN, USA.
Nelson BH; Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, Canada.
Ramus SJ; University of New South Wales, Adult Cancer Program, Lowy Cancer Research Centre, Sydney, Australia.; University of New South Wales, School of Women's and Children's Health, Sydney, Australia.
Kommoss S; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
Talhouk A; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada.
Anglesio MS; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
DB Label: Database : MEDLINE

원문보기: Full Text (Wiley-DB) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택